FDA approves first drug for neurotrophic keratitis
The FDA has approved the first treatment for neurotrophic keratitis, which completely healed the rare disease in 70 percent of cases.
List view / Grid view
The FDA has approved the first treatment for neurotrophic keratitis, which completely healed the rare disease in 70 percent of cases.
The ‘new’ test is one currently used in Europe, however the US Food and Drug Administration have recently given approval for the high-sensitivity troponin test...
A trade deal between the UK and USA could risk increasing drug prices in the UK, which could diminish the affordability and accessibility of the NHS...
An innovative use of a known drug is showing promise as an effective treatment for preventing postoperative nausea and vomiting (PONV)....
A new study suggests breast cancer patients taking palbociclib/letrozole combination therapy should avoid foods rich in xenoestrogens...
The FDA has approved Bydureon BCise for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines...
The FDA has granted Breakthrough Therapy Designation for Tagrisso for the 1st-line treatment of patients with NSCLC...